These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 386509)

  • 1. Heparin: an old drug with a new paradigm.
    Jacques LB
    Science; 1979 Nov; 206(4418):528-33. PubMed ID: 386509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular weight of heparin versus biologic activity. Some additional considerations.
    Losito R; Losito C
    Semin Thromb Hemost; 1985 Jan; 11(1):29-33. PubMed ID: 2579437
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of heparin in current therapy of thrombotic disease].
    Komarnicki M
    Pol Arch Med Wewn; 1982 Apr; 67(4):183-7. PubMed ID: 6752906
    [No Abstract]   [Full Text] [Related]  

  • 4. The anticoagulant properties of mast cell product, chondroitin sulphate E.
    Scully MF; Ellis V; Seno N; Kakkar VV
    Biochem Biophys Res Commun; 1986 May; 137(1):15-22. PubMed ID: 3087353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale behind the development of low molecular weight heparin derivatives.
    Hirsh J; Ofosu F; Buchanan M
    Semin Thromb Hemost; 1985 Jan; 11(1):13-6. PubMed ID: 2579436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of human mast cell tryptase and eosinophil granule proteins on the kinetics of blood clotting.
    Samoszuk M; Corwin M; Hazen SL
    Am J Hematol; 2003 May; 73(1):18-25. PubMed ID: 12701115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo effects of low molecular weight heparins on experimental thrombosis and bleeding.
    Hirsh J
    Haemostasis; 1986; 16(2):82-6. PubMed ID: 3710297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of rat skin heparin chains with high affinity for antithrombin.
    Horner AA
    Biochem J; 1987 Jun; 244(3):693-8. PubMed ID: 3446185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular mechanisms of heparin action III. The anticoagulant properties of polyanetholesulfonate.
    Walker FJ; Esmon CT
    Biochem Biophys Res Commun; 1978 Aug; 83(4):1339-46. PubMed ID: 212063
    [No Abstract]   [Full Text] [Related]  

  • 10. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined dihydroergotamine and heparin prophylaxis of postoperative deep vein thrombosis: proposed mechanism of action.
    Comerota AJ; Stewart GJ; White JV
    Am J Surg; 1985 Oct; 150(4A):39-44. PubMed ID: 3901791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of heparin action by modification of its structure.
    Danishefsky I
    Fed Proc; 1977 Jan; 36(1):33-5. PubMed ID: 830555
    [No Abstract]   [Full Text] [Related]  

  • 13. [The physiological inhibitors of blood coagulation. 1. Antithrombin III (AT III)].
    Kase F; Pospísil J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(3):337-49. PubMed ID: 6194066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Sulfation and Molecular Weight on Anticoagulant Activity of Dextran.
    Drozd NN; Logvinova YS; Torlopov MA; Udoratina EV
    Bull Exp Biol Med; 2017 Feb; 162(4):462-465. PubMed ID: 28243911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin, antithrombin, and abnormal clotting.
    Rosenberg RD
    Annu Rev Med; 1978; 29():367-78. PubMed ID: 77142
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombogenicity of the injured vessel wall--role of antithrombin and heparin.
    Frebelius S; Hedin U; Swedenborg J
    Thromb Haemost; 1994 Jan; 71(1):147-53. PubMed ID: 8165634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From heparin to heparin fractions and derivatives.
    Coyne E
    Semin Thromb Hemost; 1985 Jan; 11(1):10-2. PubMed ID: 3883496
    [No Abstract]   [Full Text] [Related]  

  • 18. [Heparin anticoagulant activity: new knowledge and future prospects].
    Camici M; Giusti C; Evangelisti L
    Recenti Prog Med; 1991 Apr; 82(4):209-18. PubMed ID: 1857840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin, its fractions, fragments and derivatives. Some newer perspectives.
    Fareed J
    Semin Thromb Hemost; 1985 Jan; 11(1):1-9. PubMed ID: 3919446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
    Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
    Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.